Business News
Merck stockholders approve Schering-Plough acquisition
Aug 7, 2009, 15:56 GMT
New York - Stockholders of pharmaceutical giant Merck & Co on Friday approved a merger with competitor Schering-Plough Corp in a deal valued at 41.1 billion dollars.
The deal announced in March would double the number of medicines under the final stages of development by Merck to 18 and create the second-largest US pharmaceutical firm.
Under the agreement, Schering-Plough shareholders will receive 0.6 shares of Merck and 10.50 dollars for each share, amounting to a total of 23.61 dollars per share.
The deal is to be completed in the fourth quarter.
COMMENT
blog comments powered by DisqusLatest Headlines in Business
- 1. US unemployment drops further, but figures disappoint
- 2. Japan stocks down as euro debt outweighs positive US data
- 3. Iraq resumes oil flow after pipeline blast in Turkey
- 4. Spanish bond auction lifts eurozone worries, sinks Japan stocks
- 5. ECB holds rates, rules out early exit from emergency measures
Older Talkback
